UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia

Nature reviews cardiology, 2022-09, Vol.19 (9), p.577-592

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Diabetes care, 2009-03, Vol.32 (3), p.493-498

2009

Link zum Volltext

Verfügbarkeit prüfen

Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single‐centre randomized controlled study

Diabetes, obesity & metabolism, 2019-01, Vol.21 (1), p.84-94

2019

Link zum Volltext

Verfügbarkeit prüfen

Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD

Molecular systems biology, 2017-03, Vol.13 (3), p.916-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

Frontiers in endocrinology (Lausanne), 2020-07, Vol.11, p.474-474

2020

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein C‐III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria

Journal of internal medicine, 2022-03, Vol.291 (3), p.338-349

2022

Link zum Volltext

Verfügbarkeit prüfen

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

European heart journal, 2011-06, Vol.32 (11), p.1345-1361

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride‐rich lipoproteins

Obesity (Silver Spring, Md.), 2014-08, Vol.22 (8), p.1854-1859

2014

Link zum Volltext

Verfügbarkeit prüfen

The Contribution of GWAS Loci in Familial Dyslipidemias

PLoS genetics, 2016-05, Vol.12 (5), p.e1006078-e1006078

2016

Link zum Volltext

Verfügbarkeit prüfen

HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes

Diabetes care, 2014-08, Vol.37 (8), p.2351-2358

2014

Link zum Volltext

Verfügbarkeit prüfen

An immune response network associated with blood lipid levels

PLoS genetics, 2010-09, Vol.6 (9), p.e1001113-e1001113

2010

Link zum Volltext

Verfügbarkeit prüfen

Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes

Diabetes (New York, N.Y.), 2005-01, Vol.54 (1), p.166-174

2005

Link zum Volltext

Verfügbarkeit prüfen

Effect of HDL composition and particle size on the resistance of HDL to the oxidation

Lipids in health and disease, 2010-09, Vol.9 (1), p.104-104, Article 104

2010

Link zum Volltext

Verfügbarkeit prüfen

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study

European heart journal, 2023-10, Vol.44 (39), p.4186-4195

2023

Link zum Volltext

Verfügbarkeit prüfen

USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophages

Lipids in health and disease, 2018-12, Vol.17 (1), p.285-285, Article 285

2018

Link zum Volltext

Verfügbarkeit prüfen

High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy

PloS one, 2011-08, Vol.6 (8), p.e23589-e23589

2011

Link zum Volltext

Verfügbarkeit prüfen

ESC/EAS Guidelines for the management of dyslipidaemias

European heart journal, 2011-07, Vol.32 (14), p.1769-1818

2011

Link zum Volltext

Verfügbarkeit prüfen

HDL Subspecies in Young Adult Twins: Heritability and Impact of Overweight

Obesity (Silver Spring, Md.), 2009-06, Vol.17 (6), p.1208-1214

2009

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

Journal of the American College of Cardiology, 2008-12, Vol.52 (25), p.2190-2197

2008

Link zum Volltext

Verfügbarkeit prüfen

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Atherosclerosis, 2011-07, Vol.217 Suppl 1 (1), p.S1-44

2011

Link zum Volltext

Verfügbarkeit prüfen

OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism

Journal of molecular medicine (Berlin, Germany), 2009-08, Vol.87 (8), p.825-835

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial

Cardiovascular diabetology, 2011-11, Vol.10 (1), p.102-102

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 59

Suche als RSS-Feed

Aktive Filter

ThemaCholesterol

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(59)

Sprache

Englisch
(59)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single‐centre randomized controlled study

Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

Apolipoprotein C‐III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride‐rich lipoproteins

The Contribution of GWAS Loci in Familial Dyslipidemias

HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes

An immune response network associated with blood lipid levels

Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes

Effect of HDL composition and particle size on the resistance of HDL to the oxidation

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study

USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophages

High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy

ESC/EAS Guidelines for the management of dyslipidaemias

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

HDL Subspecies in Young Adult Twins: Heritability and Impact of Overweight

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

Aktive Filter

Suchergebnisse filtern